Ready to Use Supplementary Food in Moderate Childhood Malnutrition
- Conditions
- Moderate Acute Malnutrition
- Interventions
- Dietary Supplement: Ready to Use Supplementary FoodDietary Supplement: Premix CSB-oil treatment
- Registration Number
- NCT01147198
- Lead Sponsor
- Medecins Sans Frontieres, Netherlands
- Brief Summary
Since 2001, Ready to Use Therapeutic Foods (RUTF) are widely used to treat severe malnutrition. Their efficacy and effectiveness were proven in community therapeutic care programs. Recently, the question rose if RUTF would be more effective than enriched flours to treat moderate malnutrition.
The purpose of this study is to compare the effectiveness of Ready to Use Food Supplementary-plumpy® and Premix Corn Soy Blend with oil in term of cure rate, weight gain, duration of treatment, morbidity and mortality in the treatment of moderate acute malnutrition.
Compare the longer term effect on nutritional status and morbidity (relapse?).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 570
- all children aged 6 months to 5 years admitted to SFC outpatient care during the study period
- WHM between 70-79% (1977 NCHS/WHO standard) without edema
- approval from the caretaker
- presence of the following signs: bilateral edema, MUAC<110 mm , WHM< 70%(criteria for severe malnutrition), and medical complications necessitating hospitalisation
- refusal to participate from caretaker
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ready to Use Supplementary Food Ready to Use Supplementary Food Ready to Use Supplementary Food treatment Premix Premix CSB-oil treatment Premix Corn Soy Blend-oil treatment
- Primary Outcome Measures
Name Time Method Recovery 112 days proportion of children who recovered, defined as WHM\> 85% for two consecutive weeks
- Secondary Outcome Measures
Name Time Method average weight gain 112 days in g per kg of weight per day
Duration of treatment 112 days average length of stay in days.
Morbidity 11 months number of morbidity episodes during the treatment and six months thereafter
Trial Locations
- Locations (1)
Health Centers run by MSF and MOH
🇸🇱Bo, Sierra Leone